WAUKESHA, Wis.--(BUSINESS WIRE)--April 20, 2006--GE Healthcare, a unit of General Electric Company (NYSE:GE - News), today announced that it has received U.S. Food and Drug Administration (FDA) approval for its new mammography platform that will improve the standard of care for millions of women around the world. The Senographe® Essential is the next-generation of GE’s proven Senographe Full Field Digital Mammography systems.
